Form 10-Q · Quarterly report
Keurig Dr Pepper 10-Q, filed Aug 10, 2026
- Filed
- CIK
- 0001418135
- Accession no.
- 0001418135-26-000051
Summary
Keurig Dr Pepper reported second-quarter 2026 net sales of $7,309 million, up 75.6% year over year, and net income attributable to KDP of $142 million, or $0.04 diluted EPS, after closing its JDE Peet's acquisition on April 1, 2026 for approximately €15.1 billion ($17.4 billion). Income from operations decreased 30.1% to $628 million, and the company incurred about $624 million in pre-tax acquisition, integration, and financing costs in the first half of 2026 while planning a separation.
Key points
- KDP closed its acquisition of JDE Peet's on April 1, 2026, paying approximately €15.1 billion ($17.4 billion) in cash.
- Second-quarter 2026 net sales rose 75.6% to $7,309 million, driven largely by the JDE Peet's acquisition.
- Income from operations fell 30.1% to $628 million, and diluted EPS fell to $0.04 from $0.40.
- KDP incurred approximately $624 million in pre-tax acquisition, integration, and financing costs in the first six months of 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management's Discussion OVERVIEW KDP is a leading beverage company with more than 150 owned, licensed, and partner brands, that meet a wide range of needs and occasions. Our North American refreshment beverage business holds leadership positions across carbonated soft drinks, water, juice, and mixers, with a portfolio of iconic brands, such as Dr Pepper, Canada Dry, Mott's, A&W, Peñafiel, GHOST, 7UP, Snapple, Clamato, and Core Hydration. Our global coffee business spans more than 100 markets and includes the leading Keurig single‑serve brewing system in the U.S. and Canada, along with powerhouse brands such as Peet's, L'OR, and Jacobs, and other regional coffee leaders. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.